FabRx, a British 3D printed pharmaceuticals company, has developed personalized medicine for children with the rare metabolic disorder, maple syrup urine disease (MSUD). As a life-long condition, MSUD requires patient-specific therapies and supplements, which are currently provided manually by healthcare providers. FabRx’s 3D printed chewable tablets, called the Printlets, offers a rapid and automated alternative for the preparation of […]
29 Replies to “FabRx 3D prints personalized tablets for treatment of rare metabolic disease in children”
Comments are closed.